Stevanato Group SpA
NYSE:STVN
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.93
34.28
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one STVN stock under the Base Case scenario is 18.91 USD. Compared to the current market price of 21.78 USD, Stevanato Group SpA is Overvalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Stevanato Group SpA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for STVN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Stevanato Group SpA
Balance Sheet Decomposition
Stevanato Group SpA
Current Assets | 863.5m |
Cash & Short-Term Investments | 78m |
Receivables | 496.3m |
Other Current Assets | 289.2m |
Non-Current Assets | 1.4B |
Long-Term Investments | 5.8m |
PP&E | 1.2B |
Intangibles | 83.1m |
Other Non-Current Assets | 87m |
Current Liabilities | 477.1m |
Accounts Payable | 246.2m |
Accrued Liabilities | 1.8m |
Short-Term Debt | 512k |
Other Current Liabilities | 228.6m |
Non-Current Liabilities | 414.5m |
Long-Term Debt | 288.7m |
Other Non-Current Liabilities | 125.9m |
Earnings Waterfall
Stevanato Group SpA
Revenue
|
1.1B
EUR
|
Cost of Revenue
|
-774.6m
EUR
|
Gross Profit
|
319.5m
EUR
|
Operating Expenses
|
-142.8m
EUR
|
Operating Income
|
176.7m
EUR
|
Other Expenses
|
-62m
EUR
|
Net Income
|
114.7m
EUR
|
Free Cash Flow Analysis
Stevanato Group SpA
EUR | |
Free Cash Flow | EUR |
STVN Profitability Score
Profitability Due Diligence
Stevanato Group SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Stevanato Group SpA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
STVN Solvency Score
Solvency Due Diligence
Stevanato Group SpA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Stevanato Group SpA's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STVN Price Targets Summary
Stevanato Group SpA
According to Wall Street analysts, the average 1-year price target for STVN is 27.02 USD with a low forecast of 21.21 USD and a high forecast of 38.85 USD.
Dividends
Current shareholder yield for STVN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 4,652 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one STVN stock under the Base Case scenario is 18.91 USD.
Compared to the current market price of 21.78 USD, Stevanato Group SpA is Overvalued by 13%.